IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS:

# Drug Count
0 GEMCITABINE HYDROCHLORIDE 10
1 GEMCITABINE 9
2 BEVACIZUMAB 4
3 CARBOPLATIN 4
4 MYCOPHENOLATE MOFETIL 4
5 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 4
6 ALLOPURINOL 3
7 AMLODIPINE 3
8 CISPLATIN 3
9 DOXAZOSIN 3
See all common drugs associated with IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGCETACOPLAN 2 0.0011
1 SODIUM ZIRCONIUM CYCLOSILICATE 3 0.0007
2 GEMCITABINE HYDROCHLORIDE 10 0.0002
3 HUMAN IMMUNOGLOBULIN G 2 0.0001
4 DOXAZOSIN MESYLATE 3 0.0001
5 CISPLATIN 3 0.0000
6 PAZOPANIB HYDROCHLORIDE 1 0.0000
7 BEVACIZUMAB 4 0.0000
8 CARBOPLATIN 4 0.0000
9 PACLITAXEL 3 0.0000
See all drugs enriched for association with IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

These drug classes are most commonly taken by patients reporting IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS:

# Drug class Count
See all common drug classes associated with IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS